Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04551950
Title Bintrafusp Alfa Combination Therapy in Participants With Cervical Cancer (INTRAPID 046)
Recruitment Active, not recruiting
Gender female
Phase Phase I
Variant Requirements No
Sponsors EMD Serono Research & Development Institute, Inc.
Indications

cervical adenocarcinoma

cervical adenosquamous carcinoma

cervical squamous cell carcinoma

Therapies

Bevacizumab + Carboplatin + M7824 + Paclitaxel

Bevacizumab + Cisplatin + M7824 + Paclitaxel

Cisplatin + M7824 + Paclitaxel

Cisplatin + M7824

Carboplatin + M7824 + Paclitaxel

Age Groups: adult | senior
Covered Countries USA | ESP

Facility Status City State Zip Country Details
Stanford Health Care Hospital & Clinics Stanford California 94305 United States Details
Augusta University - formerly Georgia Regents University Augusta Georgia 30912 United States Details
Comprehensive Cancer Centers of Nevada Henderson Nevada 89074 United States Details
University of Cincinnati Physicians Group, LLC - Pharmatech Oncology, Inc Cincinnati Ohio 45206 United States Details
UT Southwestern Medical Center Dallas Texas 75390 United States Details
National Cancer Center Hospital Chuo-ku Japan Details
Saitama Medical University International Medical Center Hidaka-shi Japan Details
Cancer Institute Hospital of JFCR Koto-ku Japan Details
Osaka International Cancer Institute Osaka-shi Japan Details
Shizuoka Cancer Center Sunto-gun Japan Details
Hospital Clinic i Provincial de Barcelona - Servicio de Oncologia Barcelona Spain Details
Hospital Universitari Vall d'Hebron - Dept of Oncology Barcelona Spain Details
ICO l´Hospitalet - Hospital Duran i Reynals - Servicio de Oncologia Barcelona Spain Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field